GSK3186899
GSK3186899 (DDD-853651) is an inhibitor of cdc-2-related kinase 12 (CRK12), with an EC50 of 1.4 μM for L. donovani in an intra-macrophage assay.
Product Specifications
CAS Number
[1972617-87-0]
Product Name Alternative
DDD-853651
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/GSK3186899.html
Concentration
10mM
Purity
98.96
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=S(CCC(F)(F)F)(N[C@H]1CC[C@H](NC2=NC=C3C(NN=C3N4C[C@H](C)OCC4)=N2)CC1)=O
Molecular Formula
C19H28F3N7O3S
Molecular Weight
491.53
References & Citations
[1]Wyllie S, et al. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Nature. 2018 Aug;560 (7717) :192-197.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
Leishmania
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1485324-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1485324-02 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 Tyrosine recombinase XerC (xerC)
Ask
View Details 
MBS1485324-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Tyrosine recombinase XerC (xerC)
Ask
View Details